Tailored for hematologic cancers, the Myeloid Neoplasms Focus Panel evaluates 92 genes involved in myeloid disorders such as acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). It plays a crucial role in diagnosis, prognosis, and treatment selection by identifying mutations that can drive disease progression. The test accepts blood or bone marrow samples and is especially valuable for monitoring clonal evolution over time or detecting minimal residual disease. This panel supports precision medicine approaches and helps optimize patient management in complex hematologic cases.
Our Tests
NIPT (Non-Invasive Prenatal Test) Gender
NIPT Gender is the simplest version of the NonInvasive Prenatal Test (NIPT), designed for parents who primarily want to know their baby’s sex early in pregnancy.
NIPT (Non-Invasive Prenatal Test) Basic
NIPT Basic is the entrylevel NonInvasive Prenatal Test designed to screen for the most common chromosomal conditions in pregnancy.
NIPT (Non-Invasive Prenatal Test) Standard
NIPT Standard is a more comprehensive version of the NonInvasive Prenatal Test, designed for parents who want deeper insights into their baby’s chromosomal health.
NIPT (Non-Invasive Prenatal Test) Plus
NIPT Plus is an advanced version of the NonInvasive Prenatal Test (NIPT) designed to give expecting parents the most comprehensive view of their baby’s chromosomal health.
Comprehensive Hereditary Cancer Test (~300 genes)
Covers breast, ovarian, colorectal, prostate, pancreatic, gastric, melanoma, endocrine, and more.
Hereditary Breast and Ovarian Cancer Test (50 genes)
BRCA1/2 and related genes for breast and ovarian cancer risk.
Hereditary Prostate Cancer Test (23 genes)
Genes linked to inherited prostate cancer risk.
Hereditary Pancreatic Cancer Test (32 genes)
Genes associated with inherited pancreatic cancer risk.
Hereditary Colorectal Cancer Test (44 genes)
Genes for Lynch syndrome and other colorectal risks.